Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 1—January 2018
Research Letter

Dengue Fever in Burkina Faso, 2016

Zékiba TarnagdaComments to Author , Assana Cissé, Brice Wilfried Bicaba, Serge Diagbouga, Tani Sagna, Abdoul Kader Ilboudo, Dieudonné Tialla, Moussa Lingani, K. Appoline Sondo, Issaka Yougbaré, Issaka Yaméogo, Hyacinthe Euvrard Sow, Jean Sakandé, Lassana Sangaré, Rebecca Greco, and David J. Muscatello
Author affiliations: Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso (Z. Tarnagda, A. Cissé, S. Diagbouga, T. Sagna, A.K. Ilboudo, D. Tialla, M. Lingani); Ministère de la Santé Direction de la Lutte Contre la Maladie, Ouagadougou, Burkina Faso (B.W. Bicaba, I. Yaméogo, H.E. Sow); Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou (K.A. Sondo, J. Sakandé, L. Sangaré); Sanofi Pasteur Limited, Toronto, Ontario, Canada (I. Yougbaré); US Centers for Disease Control and Prevention, Ouagadougou (R. Greco); University of New South Wales, Sydney, New South Wales, Australia (D.J. Muscatello)

Main Article

Table

Characteristics and rRT-PCR results of patients with dengue fever, Burkina Faso, 2016*

20–29 8/35 (22.85) NA
30–39 9/35 (25.71) NA
40–49 9/35 (25.71) NA
≥50 2/35 (5.71) NA
Unknown 2/35 (5.71) NA
Sex
M 24/35 (68.57) NA
F 8/35 (22.85) NA
Unknown
 3/35 (8.57)
 NA
Molecular diagnostic
rRT-PCR trioplex 19/35 (54.3) 34.78–70.78
rRT-PCR DENV-1–4 17/19 (89.4) 75.68–103.26
DENV-1 0 (0) NA
DENV-2 11/19 (57.8) 35.69–80.09
DENV-3 6/19 (31.5) 11.57–51.57
DENV-4 0 (0) NA
DENV-2 + DENV-3 1/19 (5.26) 4.74–15.26
Unknown serotype 2/19 (10.5) 7.2–23.52

*Of the 35 patient samples used, 31 were positive and 4 were negative by SD BIOLINE Dengue Duo (Standard Diagnostics, Seoul, South Korea). DENV, dengue virus; NA, not applicable; rRT-PCR, real-time reverse transcription PCR.

Main Article

Page created: December 19, 2017
Page updated: December 19, 2017
Page reviewed: December 19, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external